Guangzhou Institute of Biomedicine and Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Guangzhou Institute of Biomedicine and Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9296
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that develops protocols for disease control and prevention. The institute conducts research in the areas of stem cell and regenerative medicine, chemical biology, immunology and infectious diseases, public health, and scientific research equipment development. Its life process and disease mechanism provide solutions to the innovation and integration of human health and disease prevention, constructing research and development base for China’s bio-medicine and health and serving national strategic demands and economic and social development. GIBH offers technical services and expertise to local universities and companies in Southern China. It provides mechanisms for controlling the transformation of adult cells into pluripotent stem cells and optimization of protocols for directed differentiation of normal and diseased human iPSCs into different cell lineages. GIBH is headquartered in Guangzhou, China.

Guangzhou Institute of Biomedicine and Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Euclises Pharma Enters into Co-Development Agreement with Guangzhou Institutes of Biomedicine 10
Casigen Pharma Enters Into Co-Development Agreement With Guangzhou Institute of Biomedicine and Health 11
Ventac Partners Enters Into Joint Venture Agreement With Guangzhou Institutes of Biomedicine 12
Guangzhou Institute of Biomedicine and Health – Key Competitors 13
Guangzhou Institute of Biomedicine and Health – Key Employees 14
Guangzhou Institute of Biomedicine and Health – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Government and Public Interest 16
May 24, 2018: Scientists in China and UK work to help tackle global health epidemics 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Key Facts 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Institute of Biomedicine and Health, Deals By Therapy Area, 2012 to YTD 2018 8
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Euclises Pharma Enters into Co-Development Agreement with Guangzhou Institutes of Biomedicine 10
Casigen Pharma Enters Into Co-Development Agreement With Guangzhou Institute of Biomedicine and Health 11
Ventac Partners Enters Into Joint Venture Agreement With Guangzhou Institutes of Biomedicine 12
Guangzhou Institute of Biomedicine and Health, Key Competitors 13
Guangzhou Institute of Biomedicine and Health, Key Employees 14
Guangzhou Institute of Biomedicine and Health, Joint Venture 15

List of Figures
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Guangzhou Institute of Biomedicine and Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Great Wolf Resorts Inc:戦略・SWOT・企業財務分析
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Quantum Fuel Systems LLC:企業の戦略的SWOT分析
    Quantum Fuel Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Boralex Inc:発電所・企業SWOT分析
    Boralex Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Trinity Industries, Inc.:企業の戦略・SWOT・財務情報
    Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dow Brasil SA:企業の戦略的SWOT分析
    Dow Brasil SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • G&W Electric Company:企業の戦略的SWOT分析
    G&W Electric Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • EnviroMission Limited:電力:M&Aディール及び事業提携情報
    Summary EnviroMission Limited (EnviroMission) is a renewable energy company. It develops solar tower technology (STT). The company owns the license to STT across the world (excluding in China). EnviroMission’s STT uses solar radiation to heat air beneath a translucent canopy to create a solar therma …
  • Heptares Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Heptares Therapeutics Ltd (Heptares), a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise …
  • Guangdong Zhongsheng Pharmaceutical Co Ltd (002317):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangdong Zhongsheng Pharmaceutical Co Ltd (Guangdong Zhongsheng Pharma) is a pharmaceutical company that develops, manufactures and supplies Chinese patent medicines, medicinal herbs and chemical medicines. The company offers its products in the form of tablets, capsules, pills, injections, …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務情報
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • China Shanshui Cement Group Limited:企業の戦略・SWOT・財務情報
    China Shanshui Cement Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Shanshui Cement Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Exxon Mobil Corporation (XOM)-石油・ガス分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …
  • Banco Daycoval SA:企業の戦略・SWOT・財務情報
    Banco Daycoval SA - Strategy, SWOT and Corporate Finance Report Summary Banco Daycoval SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MSC Industrial Direct Co Inc (MSM):企業の財務・戦略的SWOT分析
    MSC Industrial Direct Co Inc (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Altor BioScience Corp-製薬・医療分野:企業M&A・提携分析
    Summary Altor BioScience Corp (Altor BioScience) is a clinical stage biopharmaceutical company that discovers, develops and commercializes immunotherapeutic products. The company’s pipeline products include ALT-801, ALT-836, and ALT-803. Its technologies are soluble t-cell antigen receptor, inhibito …
  • Fukoku Mutual Life Insurance Company:企業の戦略・SWOT・財務分析
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Bloomberg LP:企業の戦略的SWOT分析
    Bloomberg LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • MDU Resources Group Inc (MDU):企業の財務・戦略的SWOT分析
    MDU Resources Group Inc (MDU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • iPass Inc. (IPAS):企業の財務・戦略的SWOT分析
    iPass Inc. (IPAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆